Recombinant Vaccines Market Size, Share & Industry Analysis, By Type (Subunit Vaccines and Vector-Based Vaccines), By Disease Indication (Human Papillomavirus (HPV), Hepatitis B, Herpes Zoster, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2025-2032

Last Updated: October 27, 2025 | Format: PDF | Report ID: FBI101935

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview of Key Diseases, By Key Countries/ Region, 2024
2. Regolatory Scenario by Key Countries/ Region, 2024
3. Pipeline Analysis, By Key Players
4. Technological Advancements in the Vaccines Market
5. New Product Launches, By Key Players
6. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
Global Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. S.
  2. Canada
Europe Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Bavarian Nordic
  2. GSK plc
  3. Pfizer Inc.
  4. Merck & Co., Inc.
  5. CSL
  6. Mitsubishi Chemical Group Corporation
  7. AstraZeneca
  8. Sanofi
  9. EMERGENT

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview of Key Diseases, By Key Countries/ Region, 2024
2. Regolatory Scenario by Key Countries/ Region, 2024
3. Pipeline Analysis, By Key Players
4. Technological Advancements in the Vaccines Market
5. New Product Launches, By Key Players
6. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
Global Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. S.
  2. Canada
Europe Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Recombinant Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Subunit Vaccines
  2. Vector-Based Vaccines
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Human Papillomavirus (HPV)
  2. Herpes Zoster
  3. Hepatitis B
  4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Bavarian Nordic
  2. GSK plc
  3. Pfizer Inc.
  4. Merck & Co., Inc.
  5. CSL
  6. Mitsubishi Chemical Group Corporation
  7. AstraZeneca
  8. Sanofi
  9. EMERGENT

Read Less

List of Figures

Figure 1: Global Recombinant Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Recombinant Vaccines Market Value Share (%), by Type, 2024 & 2032

Figure 3: Global Recombinant Vaccines Market Value Share (%), by Disease Indication, 2024 & 2032

Figure 4: Global Recombinant Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032

Figure 5: Global Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 6: Global Recombinant Vaccines Market Value Share (%), by Region, 2024 & 2032

Figure 7: North America Recombinant Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 8: North America Recombinant Vaccines Market Value Share (%), by Type, 2024

Figure 9: North America Recombinant Vaccines Market Value (USD billion), by Disease Indication, 2024 & 2032

Figure 10: North America Recombinant Vaccines Market Value Share (%), by Disease Indication, 2024

Figure 11: North America Recombinant Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 12: North America Recombinant Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 13: North America Recombinant Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 14: North America Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 15: North America Recombinant Vaccines Market Value (USD billion), By Country, 2024 & 2032

Figure 16: North America Recombinant Vaccines Market Value Share (%), By Country, 2024

Figure 17: Europe Recombinant Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 18: Europe Recombinant Vaccines Market Value Share (%), by Type, 2024

Figure 19: Europe Recombinant Vaccines Market Value (USD billion), by Disease Indication, 2024 & 2032

Figure 20: Europe Recombinant Vaccines Market Value Share (%), by Disease Indication, 2024

Figure 21: Europe Recombinant Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 22: Europe Recombinant Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 23: Europe Recombinant Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 24: Europe Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 25: Europe Recombinant Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 26: Europe Recombinant Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 27: Asia Pacific Recombinant Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 28: Asia Pacific Recombinant Vaccines Market Value Share (%), by Type, 2024

Figure 29: Asia Pacific Recombinant Vaccines Market Value (USD billion), by Disease Indication, 2024 & 2032

Figure 30: Asia Pacific Recombinant Vaccines Market Value Share (%), by Disease Indication, 2024

Figure 31: Asia Pacific Recombinant Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 32: Asia Pacific Recombinant Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 33: Asia Pacific Recombinant Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 34: Asia Pacific Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 35: Asia Pacific Recombinant Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 36: Asia Pacific Recombinant Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Latin America Recombinant Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 38: Latin America Recombinant Vaccines Market Value Share (%), by Type, 2024

Figure 39: Latin America Recombinant Vaccines Market Value (USD billion), by Disease Indication, 2024 & 2032

Figure 40: Latin America Recombinant Vaccines Market Value Share (%), by Disease Indication, 2024

Figure 41: Latin America Recombinant Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 42: Latin America Recombinant Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 43: Latin America Recombinant Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 44: Latin America Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 45: Latin America Recombinant Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 46: Latin America Recombinant Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 47: Middle East & Africa Recombinant Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 48: Middle East & Africa Recombinant Vaccines Market Value Share (%), by Type, 2024

Figure 49: Middle East & Africa Recombinant Vaccines Market Value (USD billion), by Disease Indication, 2024 & 2032

Figure 50: Middle East & Africa Recombinant Vaccines Market Value Share (%), by Disease Indication, 2024

Figure 51: Middle East & Africa Recombinant Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 52: Middle East & Africa Recombinant Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 53: Middle East & Africa Recombinant Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 54: Middle East & Africa Recombinant Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 55: Middle East & Africa Recombinant Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 56: Middle East & Africa Recombinant Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 57: Global Recombinant Vaccines Market Share (%), By Company, 2024

List of Tables

Table 1: Global Recombinant Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: Global Recombinant Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019–2032

Table 3: Global Recombinant Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 4: Global Recombinant Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 5: Global Recombinant Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 6: North America Recombinant Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 7: North America Recombinant Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019–2032

Table 8: North America Recombinant Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 9: North America Recombinant Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 10: North America Recombinant Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: Europe Recombinant Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 12: Europe Recombinant Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019–2032

Table 13: Europe Recombinant Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 14: Europe Recombinant Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 15: Europe Recombinant Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Recombinant Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 17: Asia Pacific Recombinant Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019–2032

Table 18: Asia Pacific Recombinant Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 19: Asia Pacific Recombinant Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 20: Asia Pacific Recombinant Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Latin America Recombinant Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 22: Latin America Recombinant Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019–2032

Table 23: Latin America Recombinant Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 24: Latin America Recombinant Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 25: Latin America Recombinant Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 26: Middle East & Africa Recombinant Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 27: Middle East & Africa Recombinant Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019–2032

Table 28: Middle East & Africa Recombinant Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 29: Middle East & Africa Recombinant Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 30: Middle East & Africa Recombinant Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 167

Buy Now

GET A FREE SAMPLE

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com